ETH Meets Boston: RETHINK Drug Discovery
When:
Friday, Oct 18, 2019 6:30p -
8:00p
Friday, Oct 18, 2019 6:30p -
8:00p
Where:
District Hall
75 Northern Avenue
Boston, MA 02210
Admission:
FREE
Categories:
Innovation, Lectures & Conferences, Tech, University
Event website:
www.bit.ly/ETH_Meets_Boston_2019
Recent advances in chemical synthesis, biological testing, and artificial intelligence (AI) allow for greater automation in the drug discovery process. AI systems that generate novel design suppositions, as well as, cope with multiple design objectives provide a basis for further automation in some aspects of drug discovery. Automation could potentially accelerate timeframes for compound design and optimization. It could also enable better decision making in early-stage pharmaceutical discovery that translates into late-stage clinical validation. However, such approaches also raise considerable conceptual, technical, and organizational challenges.
This symposium aims to address the latest advances of this rapidly progressing field of science, by bringing together leading researchers to present the state-of-the-art in drug discovery. Together they will make daring predictions surrounding the possibilities and limitations of drug discovery using machine intelligence.
